Issuu on Google+

  Consolidated Investment Analysis for Bank of America Corp.    Bank of America (NYSE: BAC)  Company Description  Bank of America Corporation is a bank holding company, and a financial holding company. The Company  is a financial institution, serving individual consumers, small and middle market businesses, large  corporations and governments with a range of banking, investing, asset management and other financial  and risk management products and services. Through its banking subsidiaries (the Banks) and various  nonbanking subsidiaries throughout the United States and in selected international markets, it provides  a range of banking and nonbanking financial services and products through six business segments:  Deposits, Global Card Services, Home Loans & Insurance, Global Banking, Global Markets, Global Wealth  & Investment Management (GWIM), with the remaining operations recorded in All Other. On January 1,  2009, the Company completed the acquisition of Merrill Lynch.  Share Statistics  Symbol      Current Price    52wk Range    Avg Vol (3m)   

BAC    13.21    13.02‐ 19.86  158,151,000 

       

EPS    Market Cap  52wk Change  P/E (ttm) 

       

‐0.20  132.55B  ‐20.23%  N/A 

Financial Summary 

On July 16, 2010, Bank of America Corp reported 2nd quarter 2010 earnings of 0.27 per share. This result exceeded the 0.22 consensus of the 23 analysts covering the company and under-performed last year's 2nd quarter results by -18.18%. The next earnings announcement is expected on October 11, 2010. Bank of America Corp reported annual 2009 losses of -0.29 per share on January 20, 2010. BAC had 2nd quarter 2010 revenues of 29.15bn. This missed the 29.83bn consensus estimate of the 15 analysts following the company. This was -8.81% below the prior year's 2nd quarter results. BAC had revenues for the full year 2009 of 119.64bn. This was 61.72% above the prior year's results.  


Analyst Consensus  Buy

Outperform

Hold

Underperform

Sell

No Opinion

This is the consensus forecast amongst 24 polled investment analysts. Against the Bank of America Corp company. Analyst Detail

Buy

Outperform

Hold

Underperform

Sell

No Opinion

Yesterday

14

7

3

0

0

0

4 weeks ago

12

7

4

0

0

0

2 months ago

14

6

3

0

0

0

3 months ago

15

6

4

0

0

0

Last year

6

5

9

1

0

0

The 23 analysts offering 12 month price targets for Bank of America Corp (BAC:NYQ) have a median target of 20.00, with a high estimate of 26.00 and a low estimate of 16.00. The median estimate represents a 51.40% increase from the last price of 13.21.  Technical Analysis Chart 

   


Consolidated Investment Analysis for International Business  Machines Inc.  International Business Machines Inc. (NYSE:IBM)  Company Description  International Business Machines Corporation (IBM) is an information technology (IT) company. The  Company operates under five segments: Global Technology Services segment (GTS); Global Business  Services segment (GBS); Software segment; System and Technology segment, and Global Financing  segment. In October 2009, IBM Corporation completed its acquisition of SPSS Inc. In November 2009,  IBM acquired Guardium. In January 2010, announced the completion of its acquisition of Lombardi. In  February 2010, the Company acquired Intelliden Inc.In March 2010, the Company completed the  acquisition of National Interest Security Company, LLC.  Share Statistics   Symbol    IBM      Current Price  128.45      52wk Range  115.15‐ 134.25    Avg Vol (3m)  7,110,990     

EPS    Market Cap  52wk Change  P/E (ttm) 

10.58  162.01B  9.92%  12.14 

Financial Summary 

On July 19, 2010, International Business Machines Corp reported 2nd quarter 2010 earnings of 2.61 per share. This result was in line with the consensus of the 20 analysts following the company and exceeded last year's 2nd quarter results by 12.50%. The next earnings announcement is expected on October 18, 2010. International Business Machines Corp reported annual 2009 earnings of 10.01 per share on January 19, 2010.  IBM had 2nd quarter 2010 revenues of 23.72bn. This missed the 24.18bn consensus estimate of the 17 analysts following the company. This was 3.79% above the prior year's 2nd quarter results. IBM had revenues for the full year 2009 of 95.76bn. This was -7.60% below the prior year's results.

 


Analyst Consensus  Buy

Outperform

Hold

Underperform

Sell

No Opinion

This is the consensus forecast amongst 21 polled investment analysts. Against the International Business Machines Corp company. Analyst Detail

Buy

Outperform

Hold

Underperform

Sell

No Opinion

Latest

12

4

8

0

0

1

4 weeks ago

11

4

8

0

0

1

2 months ago

10

5

6

0

0

1

3 months ago

10

5

7

0

0

1

Last year

8

5

9

0

0

1

The 18 analysts offering 12 month price targets for International Business Machines Corp (IBM:NYQ) have a median target of 150.00, with a high estimate of 160.00 and a low estimate of 135.00. The median estimate represents a 16.78% increase from the last price of 128.45.  Technical Analysis Chart 

 


Consolidated Investment Analysis for Goldman Sachs Group Inc.    Goldman Sachs Group Inc. (NYSE: GS)  Company Description  The Goldman Sachs Group, Inc. (Goldman Sachs) is a bank holding and a global investment banking,  securities and investment management company. The Company provides a range of financial services to  customers, including corporations, financial institutions, governments and high‐net‐worth individuals. Its  depository institution subsidiary, Goldman Sachs Bank USA (GS Bank USA), is a New York State‐chartered  bank. It operates in three segments: Investment Banking, Trading and Principal Investments and Asset  Management and Securities Services. In March 2010, the Company's subsidiaries sold the La Francia  mine and related infrastructure assets, including Concession 5160, and Adromi Capital Corp., the holder  of the La Francia II concession, to a subsidiary of The Goldman Sachs Group, Inc.  Share Statistics  Symbol    GS      Current Price  148.59      52wk Range  129.50‐ 193.60    Avg Vol (3m)  10,898,400   

EPS    Market Cap  52wk Change  P/E (ttm) 

19.82  76.62B  ‐5.51%  7.50 

Financial Summary 

On July 20, 2010, Goldman Sachs Group Inc reported 2nd quarter 2010 earnings of 2.75 per share. This result exceeded the 2.08 consensus of the 12 analysts covering the company and under-performed last year's 2nd quarter results by -44.22%. The next earnings announcement is expected on October 11, 2010. Goldman Sachs Group Inc reported annual 2009 earnings of 22.13 per share on January 21, 2010. GS had 2nd quarter 2010 revenues of 8.84bn. This bettered the 7.90bn consensus of the 2 analysts covering the company. This was -30.79% below the prior year's 2nd quarter results. GS had revenues for the full year 2009 of 45.17bn. This was 103.28% above the prior year's results.   


Buy

Outperform

Hold

Underperform

Sell

No Opinion

This is the consensus forecast amongst 21 polled investment analysts. Against the Goldman Sachs Group Inc company. Analyst Detail

Buy

Outperform

Hold

Underperform

Sell

No Opinion

Latest

12

6

3

0

0

0

4 weeks ago

12

5

4

0

0

0

2 months ago

9

3

8

0

0

0

3 months ago

10

3

8

0

0

0

Last year

9

3

8

1

0

0

The 20 analysts offering 12 month price targets for Goldman Sachs Group Inc (GS:NYQ) have a median target of 190.00, with a high estimate of 243.00 and a low estimate of 170.00. The median estimate represents a 27.87% increase from the last price of 148.59.  Technical Analysis Chart 

 


Consolidated Investment Analysis for Eli Lilly and Co. 

 

  Eli Lilly and Co. (NYSE: LLY)   Company Description  Eli Lilly and Company discovers, develops, manufactures, and sells products in one business segment,  pharmaceutical products. The Company also has an animal health business segment. It manufactures  and distributes its products through facilities in the United States, Puerto Rico, and 17 other countries.  Its products are sold in approximately 128 countries. The Company's products include Neuroscience  products, Endocrinology products, Oncology products, Cardiovascular products, Animal health products,  and other pharmaceuticals. In the United States, Eli Lilly and Company distributes pharmaceutical  products principally through independent wholesale distributors, with some sales directly to  pharmacies.  Share Statistics   Symbol      Current Price    52wk Range    Avg Vol (3m)   

LLY    34.75    32.02‐ 38.00  8,044,290 

       

EPS    Market Cap  52wk Change  P/E (ttm) 

       

4.04  38.36B  6.24%  8.60 

Financial Summary 

On July 22, 2010, Eli Lilly and Co reported 2nd quarter 2010 earnings of 1.24 per share. This result exceeded the 1.10 consensus of the 17 analysts covering the company and exceeded last year's 2nd quarter results by 10.71%. The next earnings announcement is expected on October 21, 2010. Eli Lilly and Co reported annual 2009 earnings of 4.42 per share on January 28, 2010. LLY had 2nd quarter 2010 revenues of 5.75bn. This bettered the 5.56bn consensus of the 14 analysts covering the company. This was 4.80% above the prior year's 2nd quarter results. LLY had revenues for the full year 2009 of 21.84bn. This was 7.34% above the prior year's results.

 


Analyst Consensus  Buy

Outperform

Hold

Underperform

Sell

No Opinion

This is the consensus forecast amongst 23 polled investment analysts. Against the Eli Lilly and Co company. Analyst Detail

Buy

Outperform

Hold

Underperform

Sell

No Opinion

Latest

2

1

13

5

2

0

4 weeks ago

3

0

12

5

2

0

2 months ago

3

0

12

5

1

0

3 months ago

3

0

12

5

1

0

Last year

3

1

10

5

1

0

The 16 analysts offering 12 month price targets for Eli Lilly and Co (LLY:NYQ) have a median target of 35.00, with a high estimate of 43.00 and a low estimate of 28.00. The median estimate represents a 0.72% increase from the last price of 34.75.  Technical Analysis Chart 

 


Consolidated Investment Analysis for Cisco Systems Inc.  Cisco Systems, Inc. (NASDAQ: CSCO)  Company Description  Cisco Systems, Inc. designs, manufactures and sells Internet protocol (IP)‐based networking and other  products related to the communications and information technology (IT) industry, and provides services  associated with these products and their use. The Company provides a line of products for transporting  data, voice, and video within buildings, across campuses, and around the world. Its products are  designed to transform how people connect, communicate and collaborate. The Company's products are  installed at enterprise businesses, public institutions, telecommunications companies, commercial  businesses and personal residences. It has five segments: United States and Canada, European Markets,  Emerging Markets, Asia Pacific, and Japan. The Emerging Markets theater consists of Eastern Europe,  Latin America, the Middle East and Africa and Russia and the Commonwealth of Independent States. In  December 2009, the Company completed its acquisition of Starent Networks.  Share Statistics  Symbol    CSCO    Current Price  21.36    52wk Range  20.58 27.74  Avg Vol (3m)  60,913,400 

       

EPS    Market Cap  52wk Change  P/E (ttm) 

1.18  121.99B  11.66%  18.09 

Financial Summary 

On August 11, 2010, Cisco Systems Inc reported 4th quarter 2010 earnings of 0.43 per share. This result was in line with the consensus of the 33 analysts following the company and exceeded last year's 4th quarter results by 38.71%. The next earnings announcement is expected on November 01, 2010. Cisco Systems Inc reported annual 2010 earnings of 1.61 per share on August 11, 2010. CSCO.O had 4th quarter 2010 revenues of 10.84bn. This missed the 10.87bn consensus estimate of the 32 analysts following the company. This was 4.51% above the prior year's 4th quarter results. CSCO.O had revenues for the full year 2010 of 40.04bn. This was 10.86% above the prior year's results.  


Analyst Consensus  Buy

Outperform

Hold

Underperform

Sell

No Opinion

This is the consensus forecast amongst 37 polled investment analysts. Against the Cisco Systems Inc company. Analyst Detail

Buy

Outperform

Hold

Underperform

Sell

No Opinion

Latest

25

9

7

0

1

0

4 weeks ago

24

8

7

0

1

0

2 months ago

23

9

7

0

1

0

3 months ago

20

9

6

0

1

0

Last year

14

6

14

0

0

1

The 35 analysts offering 12 month price targets for Cisco Systems Inc (CSCO:NSQ) have a median target of 30.00, with a high estimate of 35.00 and a low estimate of 18.00. The median estimate represents a 26.42% increase from the last price of 23.73.  Technical Analysis Chart 

   


Consolidated Investment Analysis for Bristol‐Myers Squibb Co.    Bristol Myers Squibb Co. (NYSE: BMY)   Company Description  Bristol‐Myers Squibb Company (BMS) is engaged in the discovery, development, licensing,  manufacturing, marketing, distribution and sale of pharmaceutical products on a global basis. The  Company's products are sold worldwide, primarily to wholesalers, retail pharmacies, hospitals,  government entities and the medical profession. It manufactures products in the United States, Puerto  Rico and in eight foreign countries. In September 2009, BMS acquired Medarex, Inc., and in December  2009, it divested the Mead Johnson Nutrition Company.  Share Statistics   Symbol      Current Price    52wk Range    Avg Vol (3m)   

BMY    26.33    21.49‐ 27.07  14,482,100 

       

EPS    Market Cap  52wk Change  P/E (ttm) 

       

5.72  45.15B  19.85%  4.60 

Financial Summary 

On July 22, 2010, Bristol-Myers Squibb Co reported 2nd quarter 2010 earnings of 0.54 per share. This result was in line with the consensus of the 17 analysts following the company and under-performed last year's 2nd quarter results by -3.57%. Bristol-Myers Squibb Co reported annual 2009 earnings of 1.85 per share on January 28, 2010.

BMY had 2nd quarter 2010 revenues of 4.77bn. This missed the 4.86bn consensus estimate of the 14 analysts following the company. This was -0.81% below the prior year's 2nd quarter results. BMY had revenues for the full year 2009 of 18.81bn. This was -8.69% below the prior year's results.     


Analyst Consensus  Buy

Outperform

Hold

Underperform

Sell

No Opinion

This is the consensus forecast amongst 19 polled investment analysts. Against the Bristol-Myers Squibb Co company. Analyst Detail

Buy

Outperform

Hold

Underperform

Sell

No Opinion

Latest

6

3

11

0

1

0

4 weeks ago

5

3

10

0

2

0

2 months ago

5

3

8

0

2

0

3 months ago

3

2

12

0

2

0

Last year

5

2

10

0

1

0

The 17 analysts offering 12 month price targets for Bristol-Myers Squibb Co (BMY:NYQ) have a median target of 26.00, with a high estimate of 30.00 and a low estimate of 20.20. The median estimate represents a -0.95% decrease from the last price of 26.25.  Technical Analysis Chart 

   


Report Disclaimer  DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE OR IN ONE  OF OUR NEWSLETTERS. We are not registered as a securities broker‐dealer or an investment advisor  either within the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities  regulatory authority. We are neither licensed nor qualified to provide investment advice.  The information contained on our website or in any of our newsletters should be viewed as commercial  advertisement and is not intended to be investment advice. Any information found on our website, or in  any of our newsletters is not provided to any particular individual with a view toward their individual  circumstances. The information contained on our website, and in any newsletter we distribute, is not an  offer to buy or sell securities. We distribute opinions, comments, and information free of charge  exclusively to individuals who wish to receive them.  Our newsletter and website have been prepared for informational purposes only and are not intended  to be used as a complete source of information on any particular company. An individual should never  invest in the securities of any of the companies profiled based solely on information contained in our  report. Individuals should assume that all information contained on our website or in one of our  newsletters about profiled companies is not trustworthy unless verified by their own independent  research.  Any individual who chooses to invest in any securities should do so with caution. Investing in securities is  speculative and carries a high degree of risk; you may lose some or all of the money that is invested.  Always research your own investments and consult with a registered investment adviser or licensed  stock broker before investing.  This report is a service of Seo Freisin, Inc., a financial public relations firm that has been compensated by  the companies profiled. All direct and third party compensation received has been disclosed on both,  this newsletter, and on our website in accordance with section 17(b) of the Securities Act of 1933. This  compensation constitutes a conflict of interest as to our ability to   remain objective in our communication regarding the profiled companies. Seo Freisin, Inc., and/or its  affiliates will hold, buy, and sell securities in the companies profiled. When compensated in shares, all  readers should be aware that it is our policy to liquidate   all shares immediately. We reserve the right to buy or sell the shares of any the companies mentioned in  any materials we produce at any time. This compensation constitutes a conflict of interest as to our  ability to remain objective in our communication regarding the profiled companies.   ChartPoppers.com is a Web site wholly‐owned by Seo Freisin, Inc. Seo Freisin, Inc., has not been  compensated for any of the Companies mentioned in this report, we also do not own any shares in the  companies discussed in this report. 


Information contained in our report will contain “forward looking statements” as defined under section  27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are  cautioned not to place undue reliance upon these forward looking statements. These forward looking  statements are subject to a number of known and unknown risks and uncertainties outside of our  control that could cause actual operations or results to differ materially from those anticipated. Factors  that could affect performance include, but are not limited to, those factors that are discussed in each  profiled company’s most recent reports or registration statements filed with the SEC. You should  consider these factors in evaluating the forward looking statements included in the report and not place  undue reliance upon such statements.  We are committed to providing factual information on the companies that are profiled. However, we do  not provide any assurance as to the accuracy or completeness of the information provided, including  information regarding a profiled company’s plans or ability to effect any planned or proposed actions.  We have no first‐hand knowledge of any profiled company’s operations and therefore cannot comment  on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical  information, dollar amounts, and market size data was provided by the subject company and related  sources which we believe to be reliable.  To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy,  completeness, reliability, or timeliness of the information provided in this report, or for any direct,  indirect, consequential, incidental, special or punitive damages that may arise out of the use of  information we provide to any person or entity (including, but not limited to, lost profits, loss  opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of  this information).  We encourage you to invest carefully and read investment information available at the websites of the  SEC at http://www.sec.gov and FINRA at http://www.finra.org   


BAC, IBM, GS, LLY, CSCO, BMY